What companies are ALKS's competitors?

Alkermes plc (ALKS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does ALKS compare to its peers?

The peer comparison table on this page shows Alkermes plc (ALKS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does ALKS operate in?

Alkermes plc (ALKS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

ALKS

Alkermes plc

NASDAQ·Drug Manufacturers, Specialty & Generic · Healthcare

$46.10$0.78−1.66%

Market cap$7.73B·Market closed·Sep 4 8:00 PM UTC

Frequently Asked Questions About ALKS

What companies are ALKS's competitors?: Alkermes plc (ALKS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does ALKS compare to its peers?: The peer comparison table on this page shows Alkermes plc (ALKS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does ALKS operate in?: Alkermes plc (ALKS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

ALKS

Alkermes plc

NASDAQ·Drug Manufacturers, Specialty & Generic · Healthcare

$46.10$0.78−1.66%

Market cap$7.73B·Market closed·Sep 4 8:00 PM UTC

Peers


ARWR	Arrowhead Pharmaceuticals, Inc.	$86.34	$12.2B
KYMR	Kymera Therapeutics, Inc.	$117.39	$9.7B
PTGX	Protagonist Therapeutics, Inc.	$145.72	$9.4B
PCVX	Vaxcyte, Inc.	$61.16	$8.8B
TGTX	TG Therapeutics, Inc.	$55.99	$8.6B
ACLX	Arcellx, Inc.	$115.07	$6.7B
PTCT	PTC Therapeutics, Inc.	$69.30	$5.8B
CRSP	CRISPR Therapeutics AG	$55.79	$5.4B
ACAD	ACADIA Pharmaceuticals Inc.	$28.02	$4.8B
AKRO	Akero Therapeutics, Inc.	$54.65	$4.5B

Frequently Asked Questions About ALKS

What companies are ALKS's competitors?: Alkermes plc (ALKS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does ALKS compare to its peers?: The peer comparison table on this page shows Alkermes plc (ALKS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does ALKS operate in?: Alkermes plc (ALKS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.